Product ID:BE SERIES AUTOMOTIVE REINHIBITOR 2
MSDS Date:06/10/1996
FSC:6850
NIIN:01-387-1095
Status Code:A
Kit Part:Y
MSDS Number: CJKVY

PRESTONE PRODUCTS CORPORATION

39 OLD RIDGEBURY ROAD
DANBURY, CT 06810-5109
US

Emergency Phone: 203-830-7800/7865

Info Phone: 203-830-7800

Preparer: JAMES L. OTTOWITZ

Cage: EO340

PRESTONE PRODUCTS CORPORATION

DANBURY, CT 06810 US

Telephone: 203-830-7865

Cage: EO340

ETHYLENE GLYCOL

CAS: 107-21-1

RTECS: KW2975000

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

SODIUM BORATE

CAS: 1303-96-4

RTECS: VZ2275000

ACGIH TLV: 5 MG/M3

SODIUM NITRATE

CAS: 7631-99-4

RTECS: WC5600000

SODIUM MOLYBDATE

CAS: 7631-95-0

RTECS: QA5075000

SODIUM PHOSPHATE (NA(H2PO4))

CAS: 7558-80-7

RTECS: WA1900000

WATER

CAS: 7732-18-5

RTECS: ZC0110000

Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Health Hazards Acute and Chronic:SWALLOWING-CARDIAC FAILURE AND
PULMONARY EDEMA MAY DEVELOP. SEVERE KIDNEY DAMAGE FOLLOWS THE
SWALLOWING OF LARGE VOLUMES OF ETHYLENE GYLCOL. MAY BE FATAL.
INHALATION-MAY CAUSE IRRITATION OF THE NOSE & THROAT WITH
HEADACHE, PARTICULARLY FROM MISTS. SKIN-NO EVIDENCE OF ADVERSE
EFFECTS FROM AVAILABLE INFORMATION. EYE-LIQUID, VAPOR AND MIST MAY
CAUSE DISCOMFORT IN THE EYE WITH PERSISTENT CONJUNCTIVITI S, SEEN
AS SLIGHT EXCESS REDNESS OR CONJUNCTIVITIS.
Effects of Overexposure:SWALLOWING MAY CAUSE ABDOMINAL DISCOMFORT OR
PAIN, NAUSEA, VOMITING, DIZZINESS, DROWSINESS, MALIASE, BLURRING OF
VISION, IRRITABILITY, LUMBER PAIN, OLIGURIS, AND CENTRAL NERVOUS
SYSTEM EFFECTS, INCLUD ING IRREGULAR EYE MEVEMENT, CONVULSION AND
COMA. INHALATION OF MIST MAY PRODUCE SIGNS OF CENTRAL NERVOUS
SYSTEM INVOLVEMENT, PARTICULARLY DIZZINESS AND NYSTAGMUS. URIC ACID
METABOLISM MAY BE INHIBITED RESULTING IN ELEVATED URIC ACID
LEVELS.
Medical Cond Aggravated by Exposure:MAY AGGRAVATE KIDNEY DISEASE,
ANEMIA AND GOUT.

First Aid:SWALLOWING-GIVE TWO GLASSES OF WATER & INDUCE VOMITING
IMMEDIATELY. GET MEDICAL HELP URGENTLY BY CALLING A PHYSICIAN,
EMERGENCY ROOM/ POISON CONTROL CENTER. SKIN-REMOVE CONTAMINATED
CLOTHES. IMMEDIATE LY WASH ALL AFFECTED AND EXPOSED AREAS WITH SOAP
& COPIOUS AMOUNTS OF WATER. IF IRRITATION OR REDNESS DEVELOPS &
PERSISTS, SEEK MEDICAL ATTENTION. INHALATION-IF SYMPTOMS DEVELOP,
REMOVE TO FRESH AIR. IF BREATHING BECOMES DIFFICULT, ADMINISTER
OXYGEN. ADMINISTER ARTIFICIAL RESPIRATION IF BREATHING HAS STOPPED,
& SEEK IMMEDIATE MEDICAL ATTENTION. EYES-IMMEDIATELY FLUSH WITH
COPIOUS AMOUNTS OF CLEAN WATER USING A STEADY STREAM FOR 15 MIN.

Flash Point Method:TOC
Flash Point:NO FLASH TO BOIL
Autoignition Temp:Autoignition Temp Text:N/D
Lower Limits:N/D
Upper Limits:N/D
Extinguishing Media:USE WATER FOG, FOAM, CARBON DIOXIDE, DRY CHEMICAL
Fire Fighting Procedures:USE POSITIVE PRESSURE SELF-CONTAINED BREATHING
APPARATUS WHEN ENTERING A CONFINED SPACE.
Unusual Fire/Explosion Hazard:NONE

Spill Release Procedures:WEAR APPROPIATE PROTECTIVE EQUIPMENT. COLLECT
FOR DISPOSAL USING ABSORBENT MATERIAL, IE. VERMICULITE OR SIMILIAR
MATERIAL.

Handling and Storage Precautions:KEEP TIGHTLY CLOSED. DO NOT STORE IN
OPEN OR UNLABELED CONTAINERS. WASH EXPOSED SKIN THOROUGHLY WITH
SOAP AND WATER AFTER USE. STORE IN A COOL, WELL VENTILATED AREA.
STORE AWAY FROM INCOMPATIBLE MATER IALS. DO NOT MIX THIS CHEMICAL
DIRECTLY WITH ANY OTHER CHEMICAL. HAZARDOUS REACTION MAY OCCUR!
Other Precautions:PREVENT CONTACT WITH THE EYES, SKIN AND CLOTHING.
WEAR PROTECTIVE CLOTHING WHEN HANDLING. IMMEDIATELY REMOVE
CONTAMINATED CLOTHING AND LAUNDER BEFORE REUSE. DO NOT BREATHE
VAPORS OR MISTS THAT MAY BE GENERATED IN USING THE CHEMICALS. USE
ONLY WITH ADEQUATE VENTILATION.

Respiratory Protection:FOR OPERATIONS WHERE THE TLV MAY BE EXCEEDED, A
NIOSH/MSHA APPROVED RESPIRATOR WITH AN ORGANIC VAPOR CARTRIDGE AND
A DUST/MIST PRE-FILTER OR A SUPPLIED AIR RESPIRATOR IS RECOMMENDED.
EQUIPMENT SELECTI ON DEPENDS ON CONTAINMENT TYPE AND CONCENTRATION,
SELECT IN ACCORDANCE WITH 29 CFR 1910.134 & GOOD INDUSTRIAL HYGIENE
PRACTICE.
Ventilation:GENERAL VENTILATION SHOULD BE ADEQUATE FOR NORMAL USE AT
AMBIENT TEMPERATURES. FOR OPERATIONS WHERE THE MATERIAL IS HEATED
OR MISTED AND THE TLV MAY BE EXCEEDED
Protective Gloves:NEOPRENE OR PVC COATED, GLOVES RECOMMENDED WHERE
NEEDED.
Eye Protection:SPLASH-PROOF GOGGLES RECOMMENDED.
Other Protective Equipment:PROTECTIVE CLOTHING IF NEEDED TO AVOID
PROLONGED/REPEATED SKIN CONTACT. SUITABLE WASHING AND EYE FLUSHING
FACILITIES SHOULD BE AVAILABLE IN THE WORK AREA. CONTAMINATED
CLOTHING SHOULD BE REMOVED/WASHED.
Work Hygienic Practices:WASH EXPOSED SKIN THOROUGHLY AFTER USE.
Supplemental Safety and Health
USE ONLY AS DIRECTED. EMPTY CONTAINERS RETAIN PRODUCT RESIDUES AND MAY
BE DANGEROUS. FOLLOW ALL RECOMMENDED PRECAUTIONS IN HANDLING EMPTY
CONTAINERS. WHEN EMPTY, IMMEDIATELY REPLACE CAP AND DISPOSE PR
OPERLY. DO NOT RESUE EMPTY CONTAINERS. DO NOT CUT ON OR WELD NEAR
CONTAINERS, EVEN EMPTY.

HCC:N1
Boiling Pt:>103.9C, 219.F
Melt/Freeze Pt:=-15.C, 5.F
Vapor Pres:<0.1MMHG
Vapor Density:N/D
pH:6.9
Viscosity:NDP
Evaporation Rate & Reference:N/D (BUTYL ACETATE=1)
Solubility in Water:N/DETERMINED
Appearance and Odor:BLUE-GREEN
Percent Volatiles by Volume:NONE

Stability Indicator/Materials to Avoid:YES
NORMALLY UNREACTIVE; HOWEVER, AVOID STRONG BASES, STRONG ACIDS,STRONG
OXIDIZING AGENTS AND MATERIALS REACTIVE WITH HYDROXYL COMPOUNDS
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:BURNING MAY PRODUCE CARBON MONOXIDE
AND/OR CARBON DIOXIDE.

Waste Disposal Methods:DISPOSE IN ACCORDANCE WITH FEDERAL, STATE OR
LOCAL REGULATIONS.

Toxicological Information:THERE MAY BE CRANIAL NERVE INVOLVEMENT IN THE
LATE STAGES OF TOXICITY FROM SWALLOWED ETHYLENE GLYCOL. IN
PARTICULAR, EFFECTS HAVE BEEN REPORTED INVOLVING THE SEVENTH,
EIGHTH AND NINTH CRANIAL NERVES, PRESENTING WITH BILATERAL FACIAL
PARALYSIS, DIMINISHED HEARING AND DYSPHAGIS. INGESTION OF THE
SODIUM NITRATE COMPONENT OF THIS PRODUCT IS UNLIKELY TO RESULT IN
METHEMOGLOGINEMIA BECAUSE IT MUST BE RE DUCED TO SODIUM NITRITE BY
INTESTINAL BACTERIA. HOWEVER, THE DIAGNOSIS MUST BE CONSIDERED IN
THE SETTING OF CYANOSIS THAT DOES NOT RESPOND TO OXYGEN THERAPY.
METHYLENE BLUE IS THE ANTIDOTE.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Transport Information:NOT REGULATED.

SARA Title III Information:THIS PRODUCT CONTAINS THE FOLLOWING
CHEMICALS SUBJECT TO SARA TITLE III, SECTION 313 REPORTING:
ETHYLENE GLYCOL, CAS #107-21-1, WEIGHT 40-50%.
State Regulatory Information:CALIFORNIA PROPOSITION 65: THIS PRODUCT
CONTAINS TRACE LEVELS OF CHEMICALS WHICH THE STATE OF CALIFORNIA
HAS FOUND TO CAUSE CANCER AND/OR BIRTH DEFECTS OR OTHER
REPRODUCTIVE HARM.